NDC 80425-0188-01 - Sucralfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0188
- Requested NDC
- 80425-0188-01
- Package NDCs from labels
- 80425-0188-1, 80425-0188-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sucralfate - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0188-1 | Sucralfate | 30 in 1 BOTTLE | TABLET | 30 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0188 | SUCRALFATE TABLET [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 4 | Current NDC, Legacy NDC, 1 package rows | 20250101_d3c41720-7e1a-08c1-e053-2a95a90aba03.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0188-1 | EA - Each | 80425-0188 | 297d8d46-a744-4406-86d1-5d5d6ec62275 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sucralfate | SUCRALFATE | Bryant Ranch Prepack | 2687d670-8af6-42a2-9081-fee112e80fc0 | 2023-05-24 | Adverse reactions | 314234 XX73205DH5 |
| Sucralfate | SUCRALFATE | Bryant Ranch Prepack | 370f5ac6-2c64-42ef-ab5d-075a473012f1 | 2023-05-22 | Adverse reactions | ANDA074415 314234 XX73205DH5 |
| Sucralfate | SUCRALFATE | A-S Medication Solutions | 03b66f88-d346-4260-867c-c942c4c68a79 | 2023-05-02 | Adverse reactions | ANDA074415 314234 XX73205DH5 |
| Sucralfate | SUCRALFATE | Aphena Pharma Solutions - Tennessee, LLC | b414dc07-681c-4fde-965f-09df64c015e7 | 2021-05-19 | Adverse reactions | ANDA074415 314234 XX73205DH5 |
| Sucralfate | SUCRALFATE | Mylan Pharmaceuticals, Inc. | ae58c382-c1cf-4ebf-9c97-bdff0682df8b | 2020-06-12 | Adverse reactions | 314234 XX73205DH5 |
| Sucralfate | SUCRALFATE | Aphena Pharma Solutions - Tennessee, LLC | 84447e21-e311-4e9f-9065-53956e90135c | 2019-04-22 | Adverse reactions | 314234 XX73205DH5 |
| Sucralfate | SUCRALFATE | Teva Pharmaceuticals USA, Inc. | c7a43df7-eb37-4273-9250-87953b1fd270 | 2015-09-01 | Adverse reactions | 314234 XX73205DH5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.